New York State Common Retirement Fund’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,200
Closed -$258K 3303
2020
Q3
$258K Hold
14,200
﹤0.01% 2540
2020
Q2
$195K Hold
14,200
﹤0.01% 2652
2020
Q1
$203K Hold
14,200
﹤0.01% 2451
2019
Q4
$241K Hold
14,200
﹤0.01% 2658
2019
Q3
$219K Hold
14,200
﹤0.01% 2725
2019
Q2
$333K Hold
14,200
﹤0.01% 2565
2019
Q1
$402K Hold
14,200
﹤0.01% 2404
2018
Q4
$428K Hold
14,200
﹤0.01% 2355
2018
Q3
$497K Hold
14,200
﹤0.01% 2411
2018
Q2
$337K Sell
14,200
-600
-4% -$14.3K ﹤0.01% 2630
2018
Q1
$379K Sell
14,800
-10,409
-41% -$224K ﹤0.01% 2471
2017
Q4
$438K Sell
25,209
-4,080
-14% -$80K ﹤0.01% 2418
2017
Q3
$810K Buy
+29,289
New +$542K ﹤0.01% 2112

New York State Common Retirement Fund's AKCA Position: Q4 2020 in Review

New York State Common Retirement Fund sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 14,200 shares — an estimated $258K sold.

New York State Common Retirement Fund first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $810K in Q3 2017. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • New York State Common Retirement Fund reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 14,200 Akcea Therapeutics Inc shares in Q4 2020, an estimated $258K.
  • New York State Common Retirement Fund first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • New York State Common Retirement Fund's Akcea Therapeutics Inc position peaked at $810K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on New York State Common Retirement Fund's 13F filing for Q4 2020, filed 8 Feb 2021.